Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

More articles from Short Communication

  • You have access
    Enhanced and Persistent Inhibition of Organic Cation Transporter 1 Activity by Preincubation of Cyclosporine A
    Erika Panfen, Weiqi Chen, Yueping Zhang, Michael Sinz, Punit Marathe, Jinping Gan and Hong Shen
    Drug Metabolism and Disposition November 2019, 47 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.119.087197
  • You have access
    The 2-Hydroxyiminostilbene Metabolite of Carbamazepine or the Supernatant from Incubation of Hepatocytes with Carbamazepine Activates Inflammasomes: Implications for Carbamazepine-Induced Hypersensitivity Reactions
    Ryuji Kato, Yoshio Ijiri, Tetsuya Hayashi and Jack Uetrecht
    Drug Metabolism and Disposition October 2019, 47 (10) 1093-1096; DOI: https://doi.org/10.1124/dmd.119.087981
  • You have access
    SULT4A1 Protects Against Oxidative-Stress Induced Mitochondrial Dysfunction in Neuronal Cells
    Mohammed I. Hossain, Joshua M. Marcus, Jun Hee Lee, Patrick L. Garcia, Jean-Philippe Gagné, Guy G. Poirier, Charles N. Falany and Shaida A. Andrabi
    Drug Metabolism and Disposition September 2019, 47 (9) 949-953; DOI: https://doi.org/10.1124/dmd.119.088047
  • You have access
    Kidney Cortical Transporter Expression across Species Using Quantitative Proteomics
    Abdul Basit, Zaher Radi, Vishal S. Vaidya, Matthew Karasu and Bhagwat Prasad
    Drug Metabolism and Disposition August 2019, 47 (8) 802-808; DOI: https://doi.org/10.1124/dmd.119.086579
  • You have access
    Effects of Epacadostat on Brain Extracellular Fluid Concentrations of Serotonin—an Intracerebral Microdialysis Study in Sprague-Dawley Rats
    Yan Zhang, Kevin Bowman, Janet Maleski, Sharon Diamond and Swamy Yeleswaram
    Drug Metabolism and Disposition July 2019, 47 (7) 710-714; DOI: https://doi.org/10.1124/dmd.118.084053
  • You have access
    Fraction Unbound for Liver Microsome and Hepatocyte Incubations for All Major Species Can Be Approximated Using a Single-Species Surrogate
    John T. Barr, Julie M. Lade, Thuy B. Tran and Upendra P. Dahal
    Drug Metabolism and Disposition April 2019, 47 (4) 419-423; DOI: https://doi.org/10.1124/dmd.118.085936
  • The MBNL/CELF Splicing Factors Regulate Cytosolic Sulfotransferase 4A1 Protein Expression during Cell Differentiation
    You have access
    The MBNL/CELF Splicing Factors Regulate Cytosolic Sulfotransferase 4A1 Protein Expression during Cell Differentiation
    Misgana Idris, Neville J. Butcher and Rodney F. Minchin
    Drug Metabolism and Disposition March 2019, 47 (3) 314-319; DOI: https://doi.org/10.1124/dmd.118.085290
  • You have access
    Suppression of Hepatic CYP3A4 Expression and Activity by 3-Methylcholanthrene in Humanized PXR-CAR-CYP3A4/3A7 Mice
    Michael Crosby and David S. Riddick
    Drug Metabolism and Disposition March 2019, 47 (3) 279-282; DOI: https://doi.org/10.1124/dmd.118.084509
  • You have access
    Age Dependency of Blood-Brain Barrier Penetration by cis- and trans-Permethrin in the Rat
    Tanzir B. Mortuza, Gaylen L. Edwards, Catherine A. White, Vandan Patel, Brian S. Cummings and James V. Bruckner
    Drug Metabolism and Disposition March 2019, 47 (3) 234-237; DOI: https://doi.org/10.1124/dmd.118.084822
  • You have access
    A Recombinant Humanized Anticocaine Monoclonal Antibody Alters the Urinary Clearance of Cocaine and Its Metabolites in Rats
    Jordan A. Marckel, Hanna N. Wetzel, Sihame Amlal, Hassane Amlal and Andrew B. Norman
    Drug Metabolism and Disposition March 2019, 47 (3) 184-188; DOI: https://doi.org/10.1124/dmd.118.083857

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 53
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics